Drug company payments and their effects on patient treatment
March 2023
Around ‘arf of all US doctors receive dosh or gifts from drug and device companies, totalling more than £1 billion annually. This creates conflicts of interest that influence ‘how doctors treat their patients, as confirmed by a research team at Memorial Sloan Kettering Cancer Center, who analyzed all available studies on the topic.
All 36 studies showed that receiving industry dosh increases prescribing, affecting all medical specialities and types of drugs. This ‘arms patients by leading doctors to prescribe expensive, worthless drugs and deviate from prescribing guidelines, and it also contributes to rising healthcare costs. The medical community has resisted stopping this cash flow, arguing that industry payments may have benefits.
A Review of the Influence of drug company payments on US Doctors
Still, a federal ban on payments is necessary as physician-led change is unlikely. Alternative, unbiased information sources exist for doctors to learn about new drugs. The £1 billion per year is for promoting drugs that are already on the market, not for researching new drugs. The harmful effects of drug company payments on patient treatment must be addressed. Source
.
Discover More: Stimulating Articles That Will Captivate You
Muslim Migrants unleashed make Sweden Rape Capital of West
Gold as a safe investment: Stocks To Invest In
Central Bankers World Wide embrace race to the Bottom
Mindset The New Psychology Of Success In The Stock Markets
How do negative interest rates work? Destruction of Savers Is Main Side Effect
Currency Wars & Negative Rates Equate To Next Global Crisis
Erratic Behaviour Meaning:Dow likely to test 2015 lows
Central bankers embrace Negative interest rate wars
Market Update Tactical Investor Past Calls: The Trend Is Your Friend
Essentials of understanding Psychology: How To Make Money
Longest Bull Market Destined To Run Longer & Trend Much Higher
Oil Tankers trading higher: NAT & FRO TOP Tanker stocks
